drugset / Trial / NCT00023634
S0114 Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian Cancer
Phase 1
Terminated
14 enrolled
SWOG Cancer Research Network
National Cancer Institute (NCI) · collab
Non-randomizedParallel-groupOpen-labelTreatment
Summary
RATIONALE: Vaccines made from a peptide may make the body build an immune response to kill cancer cells. PURPOSE: This phase I trial is studying two different vaccines to treat patients who have gastric, prostate, or ovarian cancer.
Timeline
- Start
- 2001-06
- Primary completion
- 2008-11
- Completion
- 2008-11
Outcome
Outcome not reported
Stopped (Enrollment): “lack of accrual”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GMCSF | Unknown | 100 ug | Intramuscular |
| Subject | KLH | Unknown | 100 ug | Subcutaneous |